IDEXX LABORATORIES INC /DE Revenue (ASC 606)

Quick Answer

IDEXX LABORATORIES INC /DE reported Revenue (ASC 606) of $4.30 billion for fiscal year 2025.

IDEXX LABORATORIES INC /DE Revenue (ASC 606) — Annual History

Fiscal Year Revenue (ASC 606) YoY Change
2025 $4.30B +10.4%
2024 $3.90B +6.5%
2023 $3.66B +8.7%
2022 $3.37B +4.7%
2021 $3.22B +18.8%
2020 $2.71B +12.5%
2019 $2.41B +8.8%
2018 $2.21B +12.4%
2017 $1.97B +10.9%
2016 $1.78B

Quarterly Revenue (ASC 606)

Quarter Ending Revenue (ASC 606) YoY QoQ
September 30, 2025 $1.11B +13.3% -0.4%
June 30, 2025 $1.11B +10.6% +11.1%
March 31, 2025 $998.43M +3.6% +2.3%
September 30, 2024 $975.54M +6.6% -2.8%
June 30, 2024 $1.00B +6.4% +4.1%
March 31, 2024 $964.10M +7.1% +5.3%
September 30, 2023 $915.53M +8.8% -3.0%
June 30, 2023 $943.63M +9.7% +4.8%
  • IDEXX LABORATORIES INC /DE showed an increase of +10.4% in Revenue (ASC 606) compared to the prior fiscal year.
  • Over the 2016–2025 period, IDEXX LABORATORIES INC /DE’s revenue (asc 606) has grown by 142.4% (from $1.78 billion to $4.30 billion).
  • The most recent figure is from IDEXX LABORATORIES INC /DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment